The last NR indicated financing is about to happen. They will probably do a PP at 5 cents to take us to the end of the phase 3 trials.
From the last NR
On August 14, 2018 iCo filed a short form base shelf prospectus (the "Base Shelf") with securities regulators in the provinces of British Columbia, Alberta and Ontario. The Base Shelf allows iCo to offer, from time to time in one or more public offerings, up to $25,000,000 of common shares, preferred shares, debt securities, subscription receipts, units or warrants, or any combination thereof, during the 25-month period ending September 14, 2020. iCo filed the Base Shelf to provide the Company with financing flexibility going forward.
Read more at https://www.stockhouse.com/news/press-releases/2018/11/29/ico-therapeutics-announces-third-quarter-2018-financial-results-and-corporate#1SqvfgHxgKH6qSsu.99